Pictet Asset Management
CPRX

Pictet Asset Management’s Catalyst Pharmaceutical CPRX Stock Holding History

Pictet Asset Management’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$491K Buy
19,813
+39
+0.2% +$929 ﹤0.01% 1467
2025
Q4 		$462K Buy
19,774
+2,148
+12% +$47.8K ﹤0.01% 1486
2025
Q3 		$347K Hold
17,626
– – ﹤0.01% 1568
2025
Q2 		$382K Buy
17,626
+1,657
+10% +$39.1K ﹤0.01% 1501
2025
Q1 		$387K Hold
15,969
– – ﹤0.01% 1476
2024
Q4 		$333K Buy
15,969
+3,431
+27% +$73.7K ﹤0.01% 1588
2024
Q3 		$249K Hold
12,538
– – ﹤0.01% 1706
2024
Q2 		$194K Hold
12,538
– – ﹤0.01% 1771
2024
Q1 		$200K Hold
12,538
– – ﹤0.01% 1771
2023
Q4 		$211K Hold
12,538
– – ﹤0.01% 1722
2023
Q3 		$147K Buy
+12,538
New +$168K ﹤0.01% 1759

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Pictet Asset Management's CPRX Position: Q1 2026 in Review

Pictet Asset Management increased its Catalyst Pharmaceutical (CPRX) stake by 0.2% in Q1 2026, buying an estimated $929 and bringing the position to 19,813 shares worth $491K. The position accounts for ﹤0.01% of the portfolio, ranked #1467.

Pictet Asset Management first reported a position in CPRX in Q3 2023 and has held it in 11 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • Pictet Asset Management held 19,813 shares of Catalyst Pharmaceutical worth $491K as of Q1 2026.
  • Pictet Asset Management bought 39 Catalyst Pharmaceutical shares in Q1 2026, an estimated $929.
  • Catalyst Pharmaceutical made up ﹤0.01% of Pictet Asset Management's portfolio in Q1 2026, its #1467 holding.
  • Pictet Asset Management first reported a position in Catalyst Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on Pictet Asset Management's 13F filing for Q1 2026, filed 22 Apr 2026.